Last updated: Nov 20, 2026, 12:00 AM

Kymera Therapeutics Inc Exchange (NASDAQ, USD)

KYMR

115.31
-4.33 (-3.44%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
87.13%
3 year return (CAGR)
103.03%
5 year return (CAGR)
13.14%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
10.37B
Price/Sales
101.49
Ent value
10.15B
Price/Book
6.43
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
7.02%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open125.67
Daily high126.19
Daily low119.30
Daily Volume855K
All-time high138.86
1y analyst estimate144.57
Beta2.03
EPS (TTM)-3.49
Dividend per share0.00
Ex-div date-
Next earnings date19 Feb 2026

Ready to capitalize on Kymera Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
KYMRS&P500
Current price drop from All-time high-16.96%-11.46%
Highest price drop-87.51%-56.47%
Date of highest drop27 Oct 20239 Mar 2009
Avg drop from high-46.36%-10.64%
Avg time to new high37 days12 days
Max time to new high1242 days1805 days